Sharda Cropchem Q1 FY27: Revenue up 9%, PAT falls 38% YoY

Ebitda Margin CompressionResults View source PDF Explain this filing

SHARDACROP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.5%Reaction day

₹874.90

prior close

₹855.00

announcement price

In-mkt

timing

Nifty Microcap 250market+0.5%-6.0% vs market

Pesticides & Agrochemicals peers, median of 28sector+1.1%-6.7% vs sector

On the reaction day the stock moved 6.0 pts less than Nifty Microcap 250 and 6.7 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.2

10m

-1.8

15m

-3.1

30m

-3.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.5+0.5-6.0+1.1-6.7

Next day

-6.0-0.1-5.9+1.4-7.5

-6.2+1.0-7.1+1.4-7.6

-6.2+2.3-8.6+2.5-8.7

-3.7+2.8-6.4+2.0-5.7

-5.8+4.1-9.9+1.1-6.9

-7.0+4.5-11.4+0.4-7.4

15d

-11.8+4.8-16.6-0.7-11.1

-12.1+6.4-18.5-2.3-9.8

-18.0+5.5-23.6-10.2-7.8

-21.6-1.7-19.9-17.8-3.8

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 (quarter ended June 30, 2026) unaudited results. Consolidated revenue grew about 9% to about 1,074 crore rupees versus about 985 crore last year. Net profit fell about 38% to about 88 crore from about 143 crore. Total expenses surged about 17% to about 990 crore. Basic EPS stood at 9.76 rupees versus 15.83 rupees. Auditor B S R and Co. LLP gave an unmodified opinion.

Likely market impact

Profit fell sharply despite revenue growth, showing margin pressure. Business is seasonal, so Q1 may not reflect full-year performance.